ROCHE FARMACEUTICA QUIMICA, LDA. secures contract for Bead20250399 - Immunomodulators - Ocrelizumab 300 Mg/10 Ml Sol Inj Fr 10 Ml Iv

Portugal, Aug. 29 -- Portugal based ROCHE FARMACEUTICA QUIMICA, LDA. has secured contract from Servico De Saude Da Regiao Autonoma Da Madeira, Epe-Ram for Bead20250399 - Immunomodulators - Ocrelizumab 300 Mg/10 Ml Sol Inj Fr 10 Ml Iv. The value of the contract is worth 5699880 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....